Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer

NCT01993979 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT01993979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01993979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2012
Completion date
May 31, 2022
Enrollment
261 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

transitional cell carcinoma of ureter